Six microsatellite markers on the short arm of chromosome 6 in relation to HLA-DR3 and TNF-308A in systemic lupus erythematosus

Genes and Immunity

Volumn 2, Issue 7, 2001, Pages 373-380

  Van Der Linden, M W ^a   Van Der Slik, A R ^a   Zanelli, E ^a   Giphart, M J ^a   Pieterman, E ^a   Schreuder, G M Th ^a   Westendorp, R G J ^a   Huizinga, T W J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Genetics; HLA DRB1; Susceptibility; Systemic lupus erythematosus; TNF

Indexed keywords

HLA DR ANTIGEN; HLA DR3 ANTIGEN; HLA-DRB1 ANTIGEN; MICROSATELLITE DNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CAUCASIAN; CHROMOSOME 6; CHROMOSOME MAP; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; RISK; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; CHROMOSOMES, HUMAN, PAIR 6; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HLA-DR ANTIGENS; HLA-DR3 ANTIGEN; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MICROSATELLITE REPEATS; MULTIVARIATE ANALYSIS; ODDS RATIO; PHYSICAL CHROMOSOME MAPPING; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035513853     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363794     Document Type: Article

References (43)

1. Arnett FC, Goldstein R, Duvic M, Reveille JD. Major histocompatibility complex genes in systemic lupus erythematosus, Sjogren's syndrome, and polymyositis. (Review). Am J Med 1988; 85: 38-41.
2. Hajeer AH, Dababneh A, Makki RF et al. Different gene loci within the HLA-DR and TNF regions are independently associated with susceptibility and severity in Spanish rheumatoid arthritis patients. Tissue Antigens 2000; 55: 319-325.
3. Bali D, Gourley S, Kostyu DD et al. Genetic analysis of multiplex rheumatoid arthritis families. Genes Immun 1999; 1: 28-36.
4. Obayashi H, Nakamura N, Fukui M et al. Influence of TNF microsatellite polymorphisms (TNFa) on age-at-onset of insulin-dependent diabetes mellitus. Hum Immunol 1999; 60: 974-978.
5. Albuquerque RV, Hayden CM, Palmer LJ et al. Association of polymorphisms within the tumour necrosis factor (TNF) genes and childhood asthma. Clin Exp Allergy 1998; 28: 578-584.
6. Sandberg-Wollheim M, Ciusani E, Salmaggi A, Pociot F. An evaluation of tumor necrosis factor microsatellite alleles in genetic susceptibility to multiple sclerosis. Mult Scler 1995; 1: 181-185.
7. Louis E, Peeters M, Franchimont D et al. Tumour necrosis factor (TNF) gene polymorphism in Crohn's disease (CD): influence on disease behaviour? Clin Exp Immunol 2000; 119: 64-68.
8. Wilson AG, de Vries N, Pociot F et al. An allelic polymorphism within the human TNF-alpha promoter region is strongly associated with HLA A1, B8 and DR3 alleles. J Exp Med 1993; 177: 557-560.
9. Sanchez-Mazas A, Djoulah S, Busson M et al. A linkage disequilibrium map of the MHC region based on the analysis of 14 loci haplotypes in 50 French families. Eur J Hum Genet 2000; 8: 33-41.
10. Gordon C, Ranges GE, Greenspan JS, Wofsy D. Chronic therapy with recombinant tumor necrosis factor-alpha in autoimmune NZB/NZW F1 mice. Clin Immunol Immunopathol 1989; 52: 421-434.
11. Studnicka-Bencke A, Steiner G, Petera P, Smolen JS. Tumour necrosis factor alpha and its soluble receptors parallel clinical disease activity in systemic lupus erythematosus. Br J Rheum 1996; 35: 1067-1074.
12. Sullivan KE, Wooten C, Schmeckpeper BJ, Goldman D, Petri MA. A promoter polymorphism of tumor necrosis factor alpha associated with systemic lupus erythematosus in African-Americans. Arthritis Rheum 1997; 40: 2207-2211.
13. Bouma G, Crusius JB, Oudkerk Pool M et al. Secretion of tumour necrosis factor a and lymphotoxin a in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immunol 1996; 43: 456-463.
14. Huizinga TW, Westendorp RGJ, Bollen EL et al. TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients. J Neuroimmunol 1997; 72: 149-153.
15. Rudwaleit M, Tikly M, Khamashta M et al. Interethnic differences in the association of tumor necrosis factor promoter polymorphisms with systemic lupus erythematosus. J Rheumatol 1996; 23: 1725-1728.
16. Stuber F, Udalova IA, Book M et al. -308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. J Inflamm 1995;46: 42-50.
17. Westendorp RG, Langermans JA, Huizinga TW et al. Genetic influence on cytokine production and fatal meningococcal disease [published erratum appears in Lancet 1997; 349: 656]. Lancet 1997; 349: 170-173.
18. Rood MJ, van Krugten MV, van der Linden MW et al. TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum 2000; 43: 129-134.
19. Singal DP, Li J, Ye M, Lei K. D6S273 microsatellite polymorphism and susceptibility to rheumatoid arthritis. Tissue Antigens 1998; 52:353-358.
20. d'Alfonso S, Colombo G, Della BS, Scorza R, Momigliano-Richiardi P. Association between polymorphisms in the TNF region and systemic lupus erythematosus in the Italian population. Tissue Antigens 1996; 47: 551-555.
21. Hajeer AH, Worthington J, Davies EJ et al. TNF microsatellite a2, b3 and d2 alleles are associated with systemic lupus erythematosus. Tissue Antigens 1997; 49: 222-227.
22. Tarassi K, Carthy D, Papasteriades C et al. HLA-TNF haplotype heterogeneity in Greek SLE patients. Clin Exp Rheumatol 1998; 16: 66-68.
23. Jacob CO, Fronek Z, Lewis G, Hansen JA, McDevitt HO. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor α: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 1990; 87: 1233-1237.
24. Pociot F, Briant L, Jongeneel CV et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol 1993; 23: 224-231.
25. The MHC sequencing consortium. Complete sequence and gene map of a human major histocompatibility complex. Nature 1999; 401: 921-923.
26. Dunckley H, Gatenby PA, Hawkins B, Naito S, Serjeantson SW. Deficiency of C4A is a genetic determinant of systemic lupus erythematosus in three ethnic groups. J Immunogenet 1987; 14: 209-218.
27. Ochs HD, Rosenfeld SI, Thomas ED et al. Linkage between the gene (or genes) controlling synthesis of the fourth component of complement and the major histocompatibility complex. N Engl J Med 1977; 296: 470-475.
28. Partanen J, Koskimies S, Johansson E. C4 null phenotypes among lupus erythematosus patients are predominantly the result of deletions covering C4 and closely linked 21-hydroxylase A genes. J Med Genet 1988; 25: 387-391.
29. Schur PH, Marcus-Bagley D, Awdeh Z, Yunis EJ, Alper CA. The effect of ethnicity on major histocompatibility complex complement allotypes and extended haplotypes in patients with systemic lupus erythematosus. Arthritis Rheum 1990; 33: 985-992.
30. Tappeiner G, Hintner H, Scholz S et al. Systemic lupus erythematosus in hereditary deficiency of the fourth component of complement. J Am Acad Dermatol 1982; 7: 66-79.
31. Ulgiati D, Abraham LJ. Comparative analysis of the disease-associated complement C4 gene from the HLA-A1, B8, DR3 haplotype. Exp Clin Immunogenet 1996; 13: 43-54.
32. Hartung K, Baur MP, Coldewey R et al. Major histocompatibility complex haplotypes and complement C4 alleles in systemic lupus erythematosus. Results of a multicenter study. J Clin Invest 1992; 90: 1346-1351.
33. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94: 3195-3199.
34. Bendtzen K, Morling N, Fomsgaard A et al. Association between HLA-DR2 and production of tumour necrosis factor alpha and interleukin 1 by mononuclear cells activated by lipopolysaccharide. Scand J Immunol 1988; 28: 599-606.
35. Somoskovi A, Zissel G, Seitzer U et al. Polymorphisms at position -308 in the promoter region of the TNF-alpha and in the first intron of the TNF-beta genes and spontaneous and lipopolysaccharide-induced TNF-alpha release in sarcoidosis. Cytokine 1999; 11: 882-887.
36. Kroeger KM, Steer JH, Joyce DA, Abraham LJ. Effects of stimulus and cell type on the expression of the -308 tumour necrosis factor promoter polymorphism. Cytokine 2000; 12: 110-119.
37. Sambrook J., Fritsch EF, Maniatis T. Analysis and cloning of eukaryotic genomic DNA. In: Nolan C, Ford N, Ferguson M (eds). Molecular Cloning: A Laboratory Manual. Second edn. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, 1989, 9, pp 9.16-9.17.
38. Udalova IA, Nedospasov SA, Webb GC, Chaplin DD, Turetskaya RL. Highly informative typing of the human TNF locus using six adjacent polymorphic markers. Genomics 1993; 16: 180-186.
39. Foissac A, Salhi M, Cambon-Thomsen A. Microsatellites in the HLA region: 1999 update. Tissue Antigens 2000; 55: 477-509.
40. Zanelli E, Jones G, Pascual M et al. The telomeric part of the HLA region predisposes to rheumatoid erthritis independent of the class II loci. Hum Immunol 2001; 62: 75-84.
41. Degli-Esposti MA, Griffiths MS, Daly LN et al. Characterization of 4AOHW cell line panel including new data for the 10IHW panel. Hum Immunol 1993; 38: 3-16.
42. Verduyn W, Doxiadis II, Anholts J et al. Biotinylated DRB sequence-specific oligonucleotides. Comparison to serologic HLA-DR typing of organ donors in eurotransplant. Hum Immunol 1993; 37: 59-67.
43. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 1995; 19: 251.